TMCI (Treace Medical Concepts) Institutional Ownership: 55.46% (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TMCI Treace Medical Concepts Inc TMCI
72 GF Score
Price $4.79
GF Value $6.35
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Treace Medical Concepts Institutional Ownership?

Treace Medical Concepts TMCI +6.21% 72 Institutional Ownership is 55.46% as of Aug. 15, 2026. GuruFocus rates TMCI with a GF Score™ of 72/100 and a GF Value™ of $6.35 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Treace Medical Concepts's institutional ownership is 55.46%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Treace Medical Concepts's Insider Ownership is 21.50%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Treace Medical Concepts's Float Percentage Of Total Shares Outstanding is 79.75%.

Treace Medical Concepts Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Treace Medical Concepts's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Treace Medical Concepts Institutional Ownership Chart

Treace Medical Concepts Historical Data

The historical data trend for Treace Medical Concepts can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 27.07 24.23 20.69 19.54 18.65 15.61 15.60 15.64 9.93 9.47
TMCI
72GF Score
Treace Medical Concepts Inc TMCI
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Treace Medical Concepts Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 55.46% mean?
Treace Medical Concepts (TMCI) has a Institutional Ownership of 55.46% as of Aug. 15, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Treace Medical Concepts and its competitors.
Is Treace Medical Concepts' Institutional Ownership too high?
Treace Medical Concepts' current Institutional Ownership is 55.46%. Overall, Treace Medical Concepts has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Treace Medical Concepts' Institutional Ownership compare to TLSI and SENS?
Treace Medical Concepts' Institutional Ownership of 55.46% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Treace Medical Concepts and its competitors. Treace Medical Concepts's current Institutional Ownership is 55.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Treace Medical Concepts stock overvalued right now?
Based on GuruFocus' analysis, Treace Medical Concepts (TMCI) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.35, compared to a current price of $4.79 — trading 24.6% below its estimated fair value. The current Institutional Ownership is 55.46%. Treace Medical Concepts' overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Treace Medical Concepts (TMCI), the current Institutional Ownership is 55.46% as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Treace Medical Concepts (TMCI) Overvalued in 2026?

Based on GuruFocus' analysis, Treace Medical Concepts stock appears to be undervalued. The current stock price of $4.79 is trading 24.6% below its estimated GF Value™ of $6.35. GuruFocus considers Treace Medical Concepts to be Modestly Undervalued.

Key valuation signals for TMCI:

  • Institutional Ownership: 55.46%
  • GF Value™: $6.35 vs. price of $4.79 (24.6% below fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the TMCI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Treace Medical Concepts Business Description

Address 100 Palmetto Park Place, Ponte Vedra, FL, USA, 32081
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
72GF Score

Get the complete analysis for TMCI

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.79
Price
$6.35
GF Value